← Leaderboards
Dong Sung An
University Of California Los Angeles
$9,622,627
Attributed
$11,180,485
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2006–23$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$11,180,485 · 7
By mechanism
R01$6,613,762 · 3
U19$3,567,939 · 2
P30$998,784 · 2
Top collaborators
- Benhur Lee5 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Zoran Galic$3,509,989
- April D Pyle$6,193,530
- Irvin S.y. Chen$31,294,828
- Sinisa Dovat$7,191,819
- Xinmin Li$1,587,798
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyCellsHematopoietic Stem CellsVectorMediatingLentivirus VectorGenesIn VivoHiv-1Mouse ModelAdverse EffectsBaseSafetyStem CellsHematopoieticGenetic EngineeringCd34 GenePharmaceutical PreparationsProgramsT-LymphocyteCcr5 GeneGene DeliveryReconstitutionHiv Infections
Grant awards (34)
Modulation of repopulation of anti HIV-1 gene-modified cells to enhance efficacy and safety$453,562
U19 · FY2023 · AI · contact PI
Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV$616,616
R01 · FY2022 · AI · contact PI
Modulation of repopulation of anti HIV-1 gene-modified cells to enhance efficacy and safety$448,040
U19 · FY2022 · AI · contact PI
Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV$625,091
R01 · FY2021 · AI · contact PI
Modulation of repopulation of anti HIV-1 gene-modified cells to enhance efficacy and safety$466,659
U19 · FY2021 · AI · contact PI
Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV$625,091
R01 · FY2020 · AI · contact PI
Modulation of repopulation of anti HIV-1 gene-modified cells to enhance efficacy and safety$468,000
U19 · FY2020 · AI · contact PI
Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV$633,566
R01 · FY2019 · AI · contact PI
Improve the engraftment of combinatorial anti-HIV-1 gene modified HSPC$285,901
U19 · FY2019 · AI · contact PI
Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV$615,353
R01 · FY2018 · AI · contact PI
Improve the engraftment of combinatorial anti-HIV-1 gene modified HSPC$291,449
U19 · FY2018 · AI · contact PI
Improve the engraftment of combinatorial anti-HIV-1 gene modified HSPC$384,429
U19 · FY2017 · AI · contact PI
Gene and Cellular Therapy Core$107,363
P30 · FY2017 · AI · contact PI
Genetic protection of hematopoietic stem cells for stable HIV control$385,000
R01 · FY2016 · AI · contact PI
Improve the engraftment of combinatorial anti-HIV-1 gene modified HSPC$374,143
U19 · FY2016 · AI · contact PI
Gene and Cellular Therapy Core$107,454
P30 · FY2016 · AI · contact PI
Improve the engraftment of combinatorial anti-HIV-1 gene modified HSPC$395,756
U19 · FY2015 · AI · contact PI
Genetic protection of hematopoietic stem cells for stable HIV control$385,000
R01 · FY2015 · AI · contact PI
Gene and Cellular Therapy Core$107,585
P30 · FY2015 · AI · contact PI
Genetic protection of hematopoietic stem cells for stable HIV control$385,000
R01 · FY2014 · AI · contact PI
Gene and Cellular Therapy Core$111,435
P30 · FY2014 · AI · contact PI
Genetic protection of hematopoietic stem cells for stable HIV control$361,900
R01 · FY2013 · AI · contact PI
Gene and Cellular Therapy Core$108,335
P30 · FY2013 · AI · contact PI
Genetic protection of hematopoietic stem cells for stable HIV control$385,000
R01 · FY2012 · AI · contact PI
Gene and Cellular Therapy Core$93,800
P30 · FY2012 · AI · contact PI
Gene and Cellular Therapy Core$149,920
P30 · FY2011 · AI · contact PI
Gene and Cellular Therapy Core$75,691
P30 · FY2010 · AI · contact PI
Investigate stability of RNA interference in human lymphocytes$337,544
R01 · FY2009 · HL · contact PI
Investigate stability of RNA interference in human lymphocytes$235,888
R01 · FY2009 · HL · contact PI
Gene and Cellular Therapy Core$71,202
P30 · FY2009 · AI · contact PI
Investigate stability of RNA interference in human lymphocytes$337,544
R01 · FY2008 · HL · contact PI
Gene and Cellular Therapy Core$65,999
P30 · FY2008 · AI · contact PI
Investigate stability of RNA interference in human lymphocytes$337,544
R01 · FY2007 · HL · contact PI
Investigate stability RNA interference human lymphocytes$347,625
R01 · FY2006 · HL · contact PI